GoingToMeet

Parallel Trade has been a major concern to the research based industry since the late 1980's. The European Commission upholds the principle of free movement of goods. National governments maintain the right to intervene on the prices of medicines. The inevitable result is price difference and parallel trade from low-priced to high-priced countries. Manufacturers complain that trade impacts their ability to invest in new products whilst traders maintain that savings from parallel trade are vital for payers. This conference will examine the real impact of parallel trade bringing expertise from all sides of the business. The focus will be on the latest developments and will explore what the future might hold for Parallel Trade and Wholesaling